Key result
Among 816 patients prescribed aspirin for primary prevention, only 6% were highly recommended to receive it, while 23% had no indication or recommendation.
Why the study?
The study investigated aspirin prescribing patterns and guideline adherence for the primary prevention of cardiovascular diseases at a teaching hospital.
Cross-Sectional (n=816)
No
A significant proportion of patients prescribed aspirin for primary cardiovascular prevention at a teaching hospital did not have a strong guideline-based indication, highlighting a need for improved adherence to prescribing guidelines.
Overuse of aspirin without strong indication warrants prescribing caution; Level 4 data leaves open whether stewardship programs improve adherence.
The present study investigates the aspirin prescribing pattern and guidelines-adherence evaluation for primary prevention of cardiovascular diseases at a teaching hospital. A total of 816 patients were included in the study, the patients who received aspirin aged 60-69 (29.65%), followed by patients aged 50-59 years old (29.53%) and 70-79 years old (22.91%). Demographic information shown that the majority of the patients were males (58.55%). The BMI revealed that 85.78% of patients were obese. The majority of the patients have diabetes 78.67%, hypertension 74.38%, and dyslipidemia 65.68%. The mean systolic blood pressure was 136 ± 7.4 and diastolic blood pressure was 74.9 ± 5.2. After applying aspirin candidacy calculation, only 6% patients were highly recommended to be on aspirin, 49% patients had reasonable recommendation of aspirin, 27% patients use aspirin based on "may be considered" recommendation, and 23% patients were on aspirin with no indication or recommendation. The study highlights the importance of following the international recommendations in aspirin prescribing, and flags the inappropriate use and prescribing by our healthcare providers. The current study encourages further investigation to be carried out which should include patient and clinician education, to well understand and alleviate the inequalities in aspirin use and adherence. Further studies are also warranted to understand of the prescribing pattern and to provide solutions to avoid aspirin associated complications.
No takes yet. Share an insight, caveat, or question.
Almalki et al. (2021) conducted a cross-sectional in Primary prevention of cardiovascular diseases (n=816). Aspirin was evaluated on Guidelines-adherence for aspirin prescribing. Among 816 patients prescribed aspirin for primary prevention, only 6% were highly recommended to receive it, while 23% had no indication or recommendation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: